Fundraising Fox

Robert Hershberg

Investor

Senior Advisor at Frazier Life Sciences Β· Director (Nominating and Corporate Governance Committee, Member; Science and Technology Committee, Member) at atai Life Sciences Β· Independent Board Member at AtaiBeckley

Greater Seattle Area

About

Rob Hershberg is Co-Founder, President, CEO and board chairman of HilleVax, and a Venture Partner with Frazier Healthcare Partners, where he has worked with the firm and its portfolio companies for 14 years. He previously co-founded and led VentiRx Pharmaceuticals, and held senior roles at Celgene (including Chief Scientific Officer and Head of Business Development & Global Alliances), Dendreon, and Corixa. He earned his undergraduate and medical degrees at UCLA and a Ph.D. from the Salk Institute, and previously served as an assistant professor at Harvard Medical School.

Invests in

Biotech

Experience

  1. AtaiBeckleyIndependent Board Membercurrent2026 β€” present
  2. Amandala NeuroIndependent Board Membercurrent2025 β€” present
  3. Denteric Pty LtdIndependent Board Membercurrent2025 β€” presentMelbourne, Victoria, Australia
  4. Vesto TherapeuticsIndependent Board Membercurrent2024 β€” presentSeattle, Washington, United States; Madrid, Spain; Lisbon, Portugal
  5. Danaher CorporationMember, Scientific Advisory Boardcurrent2021 β€” presentWashington, District of Columbia, United States
  6. RecursionBoard Member, Chairman of the Board, Lead Independent Director and Vice Chairmancurrent2020 β€” presentSalt Lake City, New York, London
  7. Skyhawk TherapeuticsMember, Scientific Advisory Boardcurrent2020 β€” presentBoston, Massachusetts, United States
  8. Frazier Life SciencesVenture Partnercurrent2020 β€” presentSeattle, Washington, United States; Menlo Park, California, United States
  9. Institute for Protein Design, University of WashingtonMember, Independent Advisory Boardcurrent2020 β€” presentSeatttle, WA
  10. Cajal NeuroscienceCo-Founder, Executive Chairman of the Boardcurrent2020 β€” presentSeattle
  11. Adaptive Biotechnologies Corp.Independent Board Membercurrent2014 β€” presentSeattle, Washington, United States
  12. Beckley PsytechBoard Member2022 β€” 2025London
  13. HilleVaxCo-Founder, CEO and Chairman of the Board2021 β€” 2025Boston, New York, Seattle
  14. CelgeneExecutive Vice President, Head of Business Development and Global Alliances2017 β€” 2020Summit, NJ
  15. CelgeneExecutive Vice President, Chief Scientific Officer2016 β€” 2020Seattle, WA and Summit, NJ
  16. CelgeneSenior Vice President, Immuno-Oncology2014 β€” 2016Greater Seattle Area
  17. VentiRx PharmaceuticalsChief Executive Officer2012 β€” 2017Seattle, WA
  18. VentiRx PharmaceuticalsPresident and Chief Medical Officer2011 β€” 2012Greater Seattle Area
  19. VentiRx PharmaceuticalsCo-Founder, Executive Vice President, Research and Development2006 β€” 2011
  20. DendreonChief Medical Officer2003 β€” 2006

Colleagues at Frazier Life Sciences

Frequently asked questions

Who is Robert Hershberg?
Rob Hershberg is Co-Founder, President, CEO and board chairman of HilleVax, and a Venture Partner with Frazier Healthcare Partners, where he has worked with the firm and its portfolio companies for 14 years. He previously co-founded and led VentiRx Pharmaceuticals, and held senior roles at Celgene (including Chief Scientific Officer and Head of Business Development & Global Alliances), Dendreon, and Corixa. He earned his undergraduate and medical degrees at UCLA and a Ph.D. from the Salk Institute, and previously served as an assistant professor at Harvard Medical School.
Where does Robert Hershberg work?
Robert Hershberg is Senior Advisor at Frazier Life Sciences.
What does Robert Hershberg invest in?
Robert Hershberg invests in Biotech.
Where did Robert Hershberg go to school?
Robert Hershberg studied at UCLA (MD, PhD); UCLA (Molecular Biology).

Founder mafias

Same school

Shared employers